go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Reckitt Benckiser Ireland Limited

Reckitt Benckiser Ireland Limited
7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 468 9200
Fax: +353 1 468 9299


Summary of Product Characteristics last updated on medicines.ie: 09/05/2011
SPC Karvol Decongestant Capsules

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Karvol Decongestant Capsules


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each capsule contains

Chlorbutanol Hemihydrate

2.25mg

Levomenthol

35.55mg

Pine Oil Sylvestris blend

9mg

Terpineol

66.6mg

Thymol

3.15mg

Pumilio Pine Oil blend

103.05mg

For a full list of excipients, see section 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Inhalation vapour, Capsule.

Light brown, flask-shaped capsule containing a slightly yellow oil with a characteristic odour.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the symptomatic relief of nasal congestion and colds in the head.


Go to top of the page
4.2 Posology and method of administration

Babies over three months and young children:

Snip top off capsule and squeeze contents onto a handkerchief tied securely near to, but out of reach of the child.

Older children and adults:

Snip tip off capsule carefully, pointing top downwards and away from the face. Carefully sprinkle the contents onto bedding or material, avoiding the possibility of skin contact.

Alternatively, add to a pint of hot water and inhale vapour freely.

Elderly:

There is no need to modify the administration of this preparation for use by the elderly.

Children under 3 months:

Not recommended for children under 3 months of age.


Go to top of the page
4.3 Contraindications

Children under 3 months of age.


Go to top of the page
4.4 Special warnings and precautions for use

Avoid contact with the eyes and prolonged contact with the skin.

If symptoms persist consult your doctor.

Keep all medicines out of the reach of children.

Do not take internally


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.


Go to top of the page
4.6 Pregnancy and lactation

The safety of Karvol in pregnancy and lactation has not been established, but is not expected to constitute a hazard. Seek doctor or pharmacist's advice when pregnant.

If using hot water to vaporise the product the water should be not boiling. Care should be taken with hot water to avoid spillage and scalds. Children should not be left alone with hot water.


Go to top of the page
4.7 Effects on ability to drive and use machines

No clinically significant interactions known.


Go to top of the page
4.8 Undesirable effects

The safety of Karvol in pregnancy and lactation has not been established, but is not expected to constitute a hazard.


Go to top of the page
4.9 Overdose

Symptoms of overdose include nausea, vomiting, colic, headache, dizziness, a feeling of warmth, delirium, muscle twitching, epileptiform convulsions, depressed respiration, CNS depression and coma. Initial treatment consists of emptying the stomach by lavage and aspiration. Administer a saline laxative such as sodium sulphate and activated charcoal by mouth.

Convulsions may be controlled with diazepam or thiopentone sodium.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Chlorbutol, levomenthol, pine oil, terpineol and thymol are volatile substances and are thought to produce an irritant effect on the respiratory tract, possibly via a nasal pulmonary arc.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

Cinnamon Oil

Macrogol- 20 Stearate

Polysorbate 80

Macrogol 400

Triacetin

Capsule Shell

Gelatin

Glycerol

Purified water


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

AL / PVC/PVDC blister containing 10, 12, 24 capsules. Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Ireland Ltd

7 Riverwalk

Citywest Business Campus

Dublin 24

Ireland


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 979/61/1


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

1st April 1983 / 1st April 2008


Go to top of the page
10. DATE OF REVISION OF THE TEXT

April 2011



Link to this document from your website:
http://www.medicines.ie/medicine/12398/SPC/Karvol+Decongestant+Capsules/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Chlorbutol Hemihydrate
   Levomenthol
   Pine oil sylvestris
   Terpineol
   Thymol
   Pumilio pine oil

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo